4.3 Article

The importance of TRPV1-sensitisation factors for the development of neuropathic pain

Journal

MOLECULAR AND CELLULAR NEUROSCIENCE
Volume 65, Issue -, Pages 1-10

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.mcn.2015.02.001

Keywords

TRPV1 sensitisation; DRG; Neuropathic pain; Neuronal inflammation; CCI

Categories

Funding

  1. KNOW - Ministry of Science and Higher Education, Republic of Poland
  2. [LIDER/29/60/L-2/10/NCBiR/2011]

Ask authors/readers for more resources

Transient receptor potential vanilloid type 1 (TRPV1), classically associated with transduction of high-temperature and low-pH pain, underlies pain hypersensitivity in neuropathic pain. The molecular regulation of TRPV1 channel activity is not yet fully understood. Therefore, we investigated factors regulating sensitisation of this receptor during development of neuropathic pain in a rat model of chronic construction injury (CCI) in the dorsal root ganglia (DRG). In the rat CCI model, elevated levels of pro-inflammatory cytokines (TNF alpha, IL-1 beta and IL-6) in DRG corresponded to development of neuropathic pain. We assessed the expression of known kinases influencing TRPV1 sensitisation at the mRNA and/or protein level. Protein kinase C epsilon (PKC epsilon) showed the strongest upregulation at the mRNA and protein levels among all tested kinases. Co-expression of PKC epsilon and TRPV1 in L5 DRG of CCI animals was high during the development of neuropathic pain. The number of neurons expressing PKCs increased throughout the experiment We provide complex data on the expression of a variety of factors involved in TRPV1 sensitisation in a CCI model of neuropathic pain. Our study supports evidence for involvement of TRPV1 in the development of neuropathic pain, by showing increased expression of interleukins and kinases responsible for the channel sensitisation. TNF alpha and NGF seem to play a role in the transition from acute to neuropathic pain, while PKCs in its maintenance. Further studies might confirm their significance as novel targets for the treatment of neuropathic pain. (C) 2015 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available